LogicBio Therapeutics General and Administrative Expenses | LOGC

General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.

What these expenses include

Salaries of administrative staff (executives, HR, accountants, legal personnel)
Office rent and utilities
Office equipment and IT infrastructure
Professional services (auditors, lawyers, consultants)
Insurance
General administrative travel and representation expenses

What the metric indicates

Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure
Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit
Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry
Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines

Annual General and Administrative Expenses LogicBio Therapeutics

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
16.2 M	12.2 M	10.4 M	6.86 M	2.3 M	1.37 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
16.2 M	1.37 M	8.23 M

Quarterly General and Administrative Expenses LogicBio Therapeutics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	3.41 M	3.26 M	3.62 M	-	4.26 M	3.76 M	4.06 M	-	3.2 M	3.03 M	3.19 M	-	2.18 M	2.52 M	2.63 M	-	2.12 M	1.42 M	918 K	-	470 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
4.26 M	470 K	2.75 M

General and Administrative Expenses of other stocks in the Biotechnology industry

Issuer	General and Administrative Expenses	Price	% 24h	Market Cap	Country
Aclaris Therapeutics ACRS	22 M	$ 5.32	0.09 %	$ 652 M	USA
ADC Therapeutics SA ADCT	36.6 M	$ 1.05	0.46 %	$ 133 M	Schweiz
Agenus AGEN	54.4 M	$ 7.21	0.7 %	$ 214 M	USA
Фармсинтез LIFE	24.1 M	-	-	-	Russia
Akebia Therapeutics AKBA	107 M	$ 0.92	1.64 %	$ 237 M	USA
Alector ALEC	54 M	$ 1.93	0.81 %	$ 199 M	USA
Amryt Pharma plc AMYT	92 M	-	-	$ 621 M	Britain
Aligos Therapeutics ALGS	20.7 M	$ 5.05	1.2 %	$ 49.9 M	USA
Alkermes plc ALKS	222 M	$ 46.07	0.09 %	$ 7.59 B	Irlanda
Allogene Therapeutics ALLO	56.8 M	$ 1.69	0.58 %	$ 373 M	USA
Alnylam Pharmaceuticals ALNY	1.21 B	$ 239.36	0.46 %	$ 31.4 B	USA
Altimmune ALT	28.1 M	$ 3.24	0.31 %	$ 285 M	USA
ALX Oncology Holdings ALXO	23.8 M	$ 1.76	0.53 %	$ 94.4 M	USA
Evelo Biosciences EVLO	29.9 M	-	-14.46 %	$ 27.9 M	USA
Amphastar Pharmaceuticals AMPH	85.9 M	$ 23.95	1.31 %	$ 1.12 B	USA
AnaptysBio ANAB	50.7 M	$ 54.31	0.15 %	$ 1.56 B	USA
Anika Therapeutics ANIK	49.1 M	$ 20.84	0.24 %	$ 299 M	USA
ANI Pharmaceuticals ANIP	318 M	$ 73.59	2.05 %	$ 1.48 B	USA
Aptevo Therapeutics APVO	11.8 M	$ 1.72	0.58 %	$ 543 K	USA
Allakos ALLK	38.8 M	-	-	$ 28.6 M	USA
Aquestive Therapeutics AQST	79.8 M	$ 4.82	0.21 %	$ 515 M	USA
Arcturus Therapeutics Holdings ARCT	46.1 M	$ 15.6	0.25 %	$ 427 M	Israel
Armata Pharmaceuticals ARMP	12.4 M	$ 4.07	2.21 %	$ 147 M	USA
Assembly Biosciences ASMB	19.6 M	$ 25.48	0.54 %	$ 286 M	USA
Actinium Pharmaceuticals ATNM	15.2 M	$ 1.24	0.79 %	$ 38.7 M	USA
AbbVie ABBV	14 B	$ 262.51	0.01 %	$ 464 B	USA
Atara Biotherapeutics ATRA	26.3 M	$ 10.11	7.1 %	$ 127 M	USA
Aurinia Pharmaceuticals AUPH	102 M	$ 16.96	5.15 %	$ 2.28 B	Canada
Autolus Therapeutics plc AUTL	132 M	$ 1.87	0.53 %	$ 498 M	Britain
Atea Pharmaceuticals AVIR	32.9 M	$ 5.15	1.24 %	$ 420 M	USA
Axon Enterprise AXON	1.04 B	$ 468.42	5.96 %	$ 36.6 B	USA
Axsome Therapeutics AXSM	63.3 M	$ 211.97	3.87 %	$ 10.5 B	USA
Aytu BioScience AYTU	17.4 M	$ 1.97	0.5 %	$ 12.4 M	USA
BridgeBio Pharma BBIO	531 M	$ 68.3	0.1 %	$ 13.1 B	USA
Bicycle Therapeutics plc BCYC	79.4 M	$ 3.64	0.68 %	$ 252 M	Britain
Black Diamond Therapeutics BDTX	16.6 M	$ 1.94	1.02 %	$ 110 M	USA
Beam Therapeutics BEAM	114 M	$ 23.1	0.15 %	$ 2.28 B	USA
Biogen BIIB	2.43 B	$ 216.01	0.42 %	$ 31.6 B	USA
BioLineRx Ltd. BLRX	3.14 M	$ 2.48	0.79 %	$ 6.11 B	Israel
AbCellera Biologics ABCL	83.2 M	$ 11.67	2.28 %	$ 3.49 B	Canada
Benitec Biopharma BNTC	27.8 M	$ 11.04	0.9 %	$ 514 M	USA
Checkmate Pharmaceuticals CMPI	15.7 M	-	-	$ 231 M	USA
Burford Capital Limited BUR	38.4 M	$ 3.87	0.8 %	$ 848 M	Britain
Clovis Oncology CLVS	33.3 M	-	-7.23 %	$ 13 M	USA
Chimerix CMRX	22.2 M	-	-	$ 756 M	USA
Concert Pharmaceuticals CNCE	22.5 M	-	-	$ 401 M	USA
Cabaletta Bio CABA	29.6 M	$ 2.49	0.39 %	$ 250 M	USA
Can-Fite BioPharma Ltd. CANF	3.66 M	$ 2.24	0.89 %	$ 3.69 M	Israel
Catalyst Biosciences CBIO	20.8 M	$ 17.18	1.7 %	$ 1.53 B	USA
C4 Therapeutics CCCC	36.2 M	$ 3.45	0.58 %	$ 286 M	USA